Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 36 (6) , 617-619
- https://doi.org/10.1007/bf00637746
Abstract
The skin reactivity to histamine was measured in 10 healthy and 10 atopic subjects after the ingestion of single doses of loratadine 10 mg, cetirizine diHCl 10 mg and placebo, in a double-blind cross-over randomized study. The anti-H1 effect of cetirizine diHCl proved to be significantly more rapid, more pronounced and longer lasting than that of loratadine.This publication has 14 references indexed in Scilit:
- Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reactionJournal of Allergy and Clinical Immunology, 1989
- 176 Effects of cetirizine on mast cell mediator release and cellular traffic during the cutaneous late phase response(LPR)Journal of Allergy and Clinical Immunology, 1988
- Receptor effects of cetirizine.1987
- Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivoClinical and Experimental Allergy, 1987
- Antiallergic activity of loratadine, a non‐sedating antihistamineAllergy, 1986
- SUPPRESSION OF HISTAMINE-INDUCED WHEAL RESPONSE BY LORATADINE (SCH-29851) OVER 28 DAYS IN MAN1986
- 248 Astemizole, a H1-antagonist, in allergic asthmaJournal of Allergy and Clinical Immunology, 1985
- Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamineInflammation Research, 1984
- Effect of an H1 Blocker, Chlorpheniramine, on Inhalation Tests with Histamine and Allergen in Allergic AsthmaChest, 1980
- The effect of H and H blockade on cutaneous histamine response in manJournal of Allergy and Clinical Immunology, 1980